Recently, miR-93 has been introduced to be a critical player in insulin resistance and proliferative status of GCs in PCOS via targeting GLUT4 in adipose tissue and CDKN1A in GCs, respectively26,27. This evidence concerns the gene CDKN1A and polycystic ovary syndrome.